Gliomagenesis and the use of neural stem cells in brain tumor treatment

Pragathi Achanta, Neda I. Sedora Roman, Alfredo Quinones-Hinojosa

Research output: Contribution to journalReview article

23 Citations (Scopus)

Abstract

The role of neural stem cells (NSCs) in both the physiological and pathological processes in the brain has been refined through recent studies within the neuro-oncological field. Alterations in NSC regulatory mechanisms may be fundamental for the development and progression of malignant gliomas. A subpopulation of cells within the tumor known as brain tumor stem cells (BTSCs) have been shown to share key properties with NSCs. The BTSC hypothesis has significantly contributed to a potential understanding as to why brain tumors hold such dismal prognosis. On the other hand, the normal NSCs possess the capacity to migrate extensively towards the tumor bulk as well as to lingering neoplastic regions of the brain. The tropism of NSCs towards brain tumors may provide an additional tool for the treatment of brain cancer. The creation of potential therapies through the use of NSCs has been studied and includes the delivery of gene products to specific locations of the central nervous system selectively targeting malignant brain tumor cells and maximizing the efficiency of their delivery. Here, the proposed mechanisms of how brain tumors emerge, the molecular pathways interrupted in NSC pathogenesis and the most recent preclinical results in the use of NSCs for glioma treatment are reviewed.

Original languageEnglish (US)
Pages (from-to)121-130
Number of pages10
JournalAnti-Cancer Agents in Medicinal Chemistry
Volume10
Issue number2
StatePublished - Feb 2010
Externally publishedYes

Fingerprint

Neural Stem Cells
Brain Neoplasms
Neoplastic Stem Cells
Glioma
Physiological Phenomena
Tropism
Brain
Pathologic Processes
Neoplasms
Central Nervous System

Keywords

  • Brain tumor stem cells
  • Brain tumors
  • Cell migration
  • Glioma treatment
  • Gliomagenesis
  • Neural stem cells

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Pharmacology

Cite this

Gliomagenesis and the use of neural stem cells in brain tumor treatment. / Achanta, Pragathi; Sedora Roman, Neda I.; Quinones-Hinojosa, Alfredo.

In: Anti-Cancer Agents in Medicinal Chemistry, Vol. 10, No. 2, 02.2010, p. 121-130.

Research output: Contribution to journalReview article

@article{0fe56372c9944f5885a25f549832b215,
title = "Gliomagenesis and the use of neural stem cells in brain tumor treatment",
abstract = "The role of neural stem cells (NSCs) in both the physiological and pathological processes in the brain has been refined through recent studies within the neuro-oncological field. Alterations in NSC regulatory mechanisms may be fundamental for the development and progression of malignant gliomas. A subpopulation of cells within the tumor known as brain tumor stem cells (BTSCs) have been shown to share key properties with NSCs. The BTSC hypothesis has significantly contributed to a potential understanding as to why brain tumors hold such dismal prognosis. On the other hand, the normal NSCs possess the capacity to migrate extensively towards the tumor bulk as well as to lingering neoplastic regions of the brain. The tropism of NSCs towards brain tumors may provide an additional tool for the treatment of brain cancer. The creation of potential therapies through the use of NSCs has been studied and includes the delivery of gene products to specific locations of the central nervous system selectively targeting malignant brain tumor cells and maximizing the efficiency of their delivery. Here, the proposed mechanisms of how brain tumors emerge, the molecular pathways interrupted in NSC pathogenesis and the most recent preclinical results in the use of NSCs for glioma treatment are reviewed.",
keywords = "Brain tumor stem cells, Brain tumors, Cell migration, Glioma treatment, Gliomagenesis, Neural stem cells",
author = "Pragathi Achanta and {Sedora Roman}, {Neda I.} and Alfredo Quinones-Hinojosa",
year = "2010",
month = "2",
language = "English (US)",
volume = "10",
pages = "121--130",
journal = "Anti-Cancer Agents in Medicinal Chemistry",
issn = "1871-5206",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Gliomagenesis and the use of neural stem cells in brain tumor treatment

AU - Achanta, Pragathi

AU - Sedora Roman, Neda I.

AU - Quinones-Hinojosa, Alfredo

PY - 2010/2

Y1 - 2010/2

N2 - The role of neural stem cells (NSCs) in both the physiological and pathological processes in the brain has been refined through recent studies within the neuro-oncological field. Alterations in NSC regulatory mechanisms may be fundamental for the development and progression of malignant gliomas. A subpopulation of cells within the tumor known as brain tumor stem cells (BTSCs) have been shown to share key properties with NSCs. The BTSC hypothesis has significantly contributed to a potential understanding as to why brain tumors hold such dismal prognosis. On the other hand, the normal NSCs possess the capacity to migrate extensively towards the tumor bulk as well as to lingering neoplastic regions of the brain. The tropism of NSCs towards brain tumors may provide an additional tool for the treatment of brain cancer. The creation of potential therapies through the use of NSCs has been studied and includes the delivery of gene products to specific locations of the central nervous system selectively targeting malignant brain tumor cells and maximizing the efficiency of their delivery. Here, the proposed mechanisms of how brain tumors emerge, the molecular pathways interrupted in NSC pathogenesis and the most recent preclinical results in the use of NSCs for glioma treatment are reviewed.

AB - The role of neural stem cells (NSCs) in both the physiological and pathological processes in the brain has been refined through recent studies within the neuro-oncological field. Alterations in NSC regulatory mechanisms may be fundamental for the development and progression of malignant gliomas. A subpopulation of cells within the tumor known as brain tumor stem cells (BTSCs) have been shown to share key properties with NSCs. The BTSC hypothesis has significantly contributed to a potential understanding as to why brain tumors hold such dismal prognosis. On the other hand, the normal NSCs possess the capacity to migrate extensively towards the tumor bulk as well as to lingering neoplastic regions of the brain. The tropism of NSCs towards brain tumors may provide an additional tool for the treatment of brain cancer. The creation of potential therapies through the use of NSCs has been studied and includes the delivery of gene products to specific locations of the central nervous system selectively targeting malignant brain tumor cells and maximizing the efficiency of their delivery. Here, the proposed mechanisms of how brain tumors emerge, the molecular pathways interrupted in NSC pathogenesis and the most recent preclinical results in the use of NSCs for glioma treatment are reviewed.

KW - Brain tumor stem cells

KW - Brain tumors

KW - Cell migration

KW - Glioma treatment

KW - Gliomagenesis

KW - Neural stem cells

UR - http://www.scopus.com/inward/record.url?scp=77950814642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950814642&partnerID=8YFLogxK

M3 - Review article

VL - 10

SP - 121

EP - 130

JO - Anti-Cancer Agents in Medicinal Chemistry

JF - Anti-Cancer Agents in Medicinal Chemistry

SN - 1871-5206

IS - 2

ER -